FFO
PRCT icon

Fortitude Family Office’s Procept Biorobotics PRCT Stock Holding History

Fortitude Family Office’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97K Buy
+176
New +$4.41K ﹤0.01% 1192
2026
Q1 		– Sell
-16
Closed -$503 – 2033
2025
Q4 		$503 Sell
16
-47
-75% -$1.56K ﹤0.01% 1710
2025
Q3 		$2.25K Hold
63
– – ﹤0.01% 1168
2025
Q2 		$3.63K Buy
+63
New +$3.56K ﹤0.01% 915

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fortitude Family Office's PRCT Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 176 shares worth $3.97K. The stake represents ﹤0.01% of the portfolio and ranks #1192 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in PRCT as recently as Q4 2025.

Fortitude Family Office first reported a position in PRCT in Q2 2025 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Fortitude Family Office held 176 shares of Procept Biorobotics worth $3.97K as of Q2 2026.
  • Procept Biorobotics was a new Fortitude Family Office position in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1192 holding.
  • Fortitude Family Office first reported a position in Procept Biorobotics in Q2 2025 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.